Human babesiosis is an important emerging tick-borne disease. Babesia diver
gens, a parasite of cattle, has been implicated as the most common agent of
human babesiosis in Europe, causing severe disease in splenectomized indiv
iduals. In the US, Babesia microti, a babesial parasite of small mammals, h
as been the cause of over 300 cases of human babesiosis since 1969, resulti
ng in mild to severe disease, even in non-splenectomised patients. Changing
ecology has contributed greatly to the increase and expansion of human bab
esiosis in the US. A relatively recently described babesial parasite, the W
A1-type, has been shown to be the causative agent in seven human cases in t
he western US. This parasite is closely related to babesial parasites isola
ted from large wild ungulates in California. Like B. microti, WA1-type para
sites cause mild to severe disease and the immunopathogenesis of these para
sites is distinctly different from each other in experimental infections of
hamsters and mice. A B. divergens-like parasite was also identified as the
cause of a fatal human babesiosis case in Missouri. Isolated cases of huma
n babesisosis have been described in Africa and Mexico, but the causative p
arasites were not well characterized. Standard diagnostic techniques for hu
man infection, such as examination of Giemsa-stained thin blood smears and
serology, have been complemented with molecular techniques, such as PCR. Cu
rrent treatment for babesiosis is focused on a regimen of clindamycin and q
uinine, although new drugs have shown promise. Prevention of infection reli
es on self-monitoring for the presence of ticks and, in some locations, tar
geted application of pesticides to decrease tick abundance. Identification
of human infection with Babesia spp. will probably increase as physicians a
nd the public become more aware of the disease, as people live and recreate
in rural tick-infested areas, and as the numbers of immunocompromised indi
viduals increase. (C) 2000 Australian Society for Parasitology Inc. Publish
ed by Elsevier Science Ltd. All rights reserved.